Vanguard Russell 2000 ETF Rating $113.92 -2.47 (-2.12%) Closing price 04:00 PM EasternExtended Trading$113.83 -0.09 (-0.08%) As of 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsNews and TrendsOptions ChainOwnershipRatingsShort Interest Vanguard Russell 2000 ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.VTWO Aggregate RatingModerate Buy 2.81Holdings in VTWO have an aggregate rating of Moderate Buy based on 341 analyst ratings issued in the past year covering 24 companies (6.9% of the portfolio).VTWO Aggregate Price Target$113.92High Prediction$113.92Average Prediction$113.92Low Prediction$113.92Holdings in VTWO have an aggregate price target of $113.92 and a range of $113.92 to $113.92 covering 24 companies (6.9% of the portfolio).VTWO Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy4 Buy rating(s)Moderate Buy19 Moderate Buy rating(s)Hold1 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Vanguard Russell 2000 ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 24 VTWO Holdings ExportWeight In ETFCompanyShare PriceConsensus RatingConsensus Price TargetPossible UpsideNumber of RatingsMarketRank™Indicator(s)ViewRatings0.34%FROGJFrog$92.33+2.6%Moderate Buy$109.48 18.6%233.6764 of 5 stars0.33%UMBFUMB Financial$133.85-0.3%Moderate Buy$167.93 25.5%164.9689 of 5 stars0.33%MOG.AMoog$375.27+2.0%Moderate Buy$462.33 23.2%43.7132 of 5 starsNews Coverage0.32%GKOSGlaukos$153.63-3.9%Moderate Buy$180.54 17.5%153.2293 of 5 starsPositive NewsAnalyst Forecast0.31%EATBrinker International$210.83+1.9%Moderate Buy$243.38 15.4%243.9261 of 5 starsTrending NewsAnalyst Forecast0.30%BTSGBrightSpring Health Services$55.78-1.4%Buy$70.71 26.8%204.6864 of 5 starsPositive News0.29%CYTKCytokinetics$65.81-2.6%Moderate Buy$103.37 57.1%202.698 of 5 starsInsider Trade0.29%KRYSKrystal Biotech$341.75-2.6%Moderate Buy$365.80 7.0%133.3266 of 5 starsPositive NewsAnalyst Forecast0.28%ONBOld National Bancorp$24.74-1.2%Moderate Buy$30.17 21.9%134.6286 of 5 starsAnalyst Forecast0.28%FCFSFirstCash$216.47-2.0%Moderate Buy$249.00 15.0%54.0947 of 5 stars0.28%CRNXCrinetics Pharmaceuticals$84.95Hold$81.00 -4.6%171.2573 of 5 stars0.28%CTRECareTrust REIT$37.13-0.8%Moderate Buy$44.50 19.8%144.7324 of 5 starsPositive News0.28%PRAXPraxis Precision Medicines$282.12-6.2%Moderate Buy$612.42 117.1%202.5254 of 5 starsHigh Trading Volume0.28%PTGXProtagonist Therapeutics$138.70-4.4%Moderate Buy$147.13 6.1%182.1058 of 5 starsPositive News0.28%TWSTTwist Bioscience$158.50-3.7%Moderate Buy$103.00 -35.0%121.8113 of 5 starsTrending NewsAnalyst ForecastInsider Trade0.28%JXNJackson Financial$129.99+0.3%Moderate Buy$133.80 2.9%71.8355 of 5 stars0.28%SMSM Energy$34.33+1.2%Moderate Buy$39.38 14.7%174.9013 of 5 stars0.27%RHPRyman Hospitality Properties$120.52-0.8%Buy$132.33 9.8%133.735 of 5 stars0.27%IDCCInterDigital$326.55-2.2%Buy$450.00 37.8%43.1198 of 5 stars0.27%VSATViasat$73.68-1.7%Moderate Buy$90.67 23.1%113.0701 of 5 starsNews CoverageInsider Trade0.26%SSRMSilver Standard Resources$36.30-5.2%Moderate Buy$42.40 16.8%113.7503 of 5 starsGap Down0.26%HQYHealthEquity$90.39-1.5%Moderate Buy$112.20 24.1%134.4993 of 5 stars0.25%HUTHut 8$102.46-3.9%Buy$143.95 40.5%243.1548 of 5 starsTrending NewsAnalyst Forecast0.25%PCVXVaxcyte$56.49-4.3%Moderate Buy$98.00 73.5%72.2754 of 5 stars This page (NASDAQ:VTWO) was last updated on 9/23/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vanguard Russell 2000 ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Vanguard Russell 2000 ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
